Advancing Second-Generation Off-the-Shelf CAR-NK Therapies for Safer, More Scalable Cancer Treatment
- Explore how CAR-engineered NK cells enhance tumour targeting, persistence, and safety
- Discuss how these next-generation, allogeneic NK products improve manufacturability, cost efficiency, and clinical accessibility
New Data